Hefei Cube Pharmaceutical Co., Ltd.

Founded in Hefei in 2002, it is a pharmaceutical research and development, production and Sales-in-one stocks shareholding enterprise. It owns three pharmaceutical industrial enterprises, one pharmaceutical commercial enterprise, --a pharmaceutical retail chain enterprise. The company has a total of eleven GMP production lines. In 2014, Cubic Co., Ltd.’s postdoctoral research workstation was officially launched. 2018, The company's API branch passed FDA inspection with zero defects. Company Honors: First Prize of Anhui Province Science and Technology Award; Legal Person of Anhui Pharmaceutical Industry Association Unit; Top 100 comprehensive strength industrial enterprises in China's chemical and pharmaceutical industry; China Pharmaceutical Industry The most investment valuable enterprise in the industry; a high-tech enterprise; an innovation pilot enterprise in Anhui Province Anhui Province Pharmaceutical Quality Award; Hefei Drug Sustained and Controlled Release Engineering Technology Center; Central Top Innovative enterprise with investment value; Class A tax paying enterprise in Anhui Province. It was successfully listed on the Shenzhen Stock Exchange in December 2020.